Research Solutions, Inc. — Form 10-Q Summary
Reporting period: The filing covers the quarter and nine months ended March 31, 2023 (the company’s fiscal third quarter), compared with the periods ended March 31, 2022. This differs from the request metadata, which says “2022 Q3.” The statements are unaudited.
Business context and financial performance
Research Solutions sells annual subscriptions to a cloud-based research platform (“Platforms”) and individual scientific, technical and medical article delivery services (“Transactions”).
| Metric | Three months ended Mar. 31, 2023 | Year-over-year change | Nine months ended Mar. 31, 2023 | Year-over-year change |
|---|---|---|---|---|
| Revenue | $10.34 million | +18.1% | $27.74 million | +13.8% |
| Platforms revenue | $2.25 million | +25.9% | $6.38 million | +30.2% |
| Transactions revenue | $8.09 million | +16.1% | $21.36 million | +9.7% |
| Gross profit / gross margin | $4.03 million / 38.9% | Margin +1.9 percentage points | $10.78 million / 38.9% | Margin +3.1 percentage points |
| Operating income (loss) | $133,139 | Prior-year loss: $339,945 | $(16,675) | Prior-year loss: $1.19 million |
| Net income (loss) | $236,842 | Prior-year loss: $340,530 | $195,877 | Prior-year loss: $1.19 million |
| Adjusted EBITDA | $559,382 | Prior year: $93,671 | $1.19 million | Prior-year loss: $252,656 |
Quarterly diluted and basic earnings per share were both $0.01. For the nine-month period, both were also $0.01. Adjusted EBITDA is a non-GAAP measure; the company cautions that it is not a substitute for GAAP results or operating cash flow.
Cash flow, debt and liquidity
- Cash and cash equivalents were $12.13 million at March 31, 2023, up $1.53 million from June 30, 2022. Current assets were $20.13 million and current liabilities $14.22 million, implying working capital of about $5.91 million.
- For the nine months, operating cash flow was $1.87 million, versus cash used of $402,711 in the prior-year period. The increase included higher deferred revenue and accounts payable/accruals; accounts receivable growth of $1.55 million was a significant offset. Operating cash flow also includes substantial noncash stock compensation.
- Investing cash outflow was $327,426, chiefly the $297,450 non-refundable deposit for the FIZ asset acquisition. Financing cash outflow was $17,056, including $74,556 of share repurchases, partly offset by option proceeds.
- No borrowings were outstanding under the revolving credit line at March 31, 2023; approximately $2.5 million was available. The line matured February 28, 2024, carried a 9% rate at quarter-end, and had financial covenants with which the company reported compliance.
Material changes, outlook and risks
- Revenue growth reflected additional platform deployments and customer expansion, higher paid article-order volume, pricing initiatives, and contribution from the FIZ contract acquisition. Gross margin improved as cost of revenue grew more slowly than revenue. Operating expenses rose 8.8% for both the quarter and nine-month comparison, including higher personnel, marketing and stock-based compensation costs.
- The FIZ Karlsruhe asset purchase transferred certain customer contracts effective January 1, 2023. The company recorded $430,788 of related intangible assets at March 31, 2023, with an estimated average useful life of 10 years, and $144,384 of contingent consideration. Some contingent payments are to continue through the quarter ending December 31, 2025.
- Following Silicon Valley Bank’s March 2023 closure, the company reported access to all deposits beginning March 14 and continued access to its credit line. At March 31, $10.47 million was held at SVB Bridge Bank, including an estimated $9.41 million above government-insured limits. The company said it was reallocating cash among three banks and evaluating banking diversification and additional lending access.
- Management gave no quantified revenue or earnings guidance in the provided filing text. It described ongoing platform development and app functionality. It said inflation had not materially affected operations to date, but future cost and interest-rate pressures could strain working capital. COVID-19’s future impact remained uncertain; the company reported no significant negative impact to date.
- Foreign-exchange movements affect operations, and the company does not hedge currency exposure. It also reported vendor concentration: two vendors represented 22% and 13% of cost/revenue-related vendor activity, respectively, for the nine months (the filing’s vendor table reports these as percentages).
Important facts for investors to verify
- Confirm the intended period: this filing is for fiscal Q3 ended March 31, 2023, not 2022 Q3.
- Track whether platform and transaction growth, gross-margin gains and positive net income persist, particularly as acquisition-related contribution develops.
- Review cash-flow quality and working-capital movements, including receivables, deferred revenue, payables and stock-based compensation.
- Monitor the concentration and insurance status of bank deposits, the company’s banking diversification, and the status and terms of the credit facility before its February 2024 maturity.
- Assess the FIZ contract-transfer performance, contingent consideration and future amortization of acquired intangibles.
- Check the filing’s reported quarterly platform-revenue increase: the revenue table implies $463,408 year over year, while one MD&A driver table states $436,408.